AzTrials
AzTrials

DiabetesNCT02888951

Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting Instructions

An observational study of Diabetes and Diabetes Mellitus, run by University Health Network, Toronto at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study evaluates the amount of fluid remaining in the stomach of diabetic patients after a standard fasting period, and compare it with non-diabetic patients coming for elective surgical procedures. Read more about this study

Who is it for?
Ages 18 to 85 years
How many people
240 participants
Where
1 siteCanada
Study dates
Aug 2016to Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Study participants will be patients whom are scheduled to undergo elective surgical procedures requiring preoperative fasting period of at least 8 hours. 240 patients will be recruited in total. One cohort consisting 120 patients will be diabetic (type 1 or 2). The other cohort consisting of 120 patients will be non-diabetic.

Who may be able to join

  • Patients scheduled for elective surgery aged 18 to 85 years
  • American Society of Anesthesia physical status classification I to III
  • Body mass index < 40 kg/ cm2.

Who cannot join

  • Pregnancy (currently or within the past 3 months)
  • Previous surgery of the upper gastrointestinal tract
  • Achalasia

Trial locations and contacts

1 site in 1 country.

Canada1 site, 1 recruiting
  • Toronto Western Hospital

    Toronto, Ontario, M5T 2S8

    Anahi Perlas, MD, (416) 603-5800 ext. 5118, anahi.perlas@uhn.ca

    Didem Bozak, (416) 603-5800 ext. 2016, didem.bozak@uhnresearch.ca

    Recruiting

Other trials in Canada

About this study

Official title: Do Standard Preoperative Fasting Instructions Ensure an Empty Stomach in Diabetic Patients? A Prospective Comparative Cohort Study

This study evaluates the amount of fluid remaining in the stomach of diabetic patients after a standard fasting period, and compare it with non-diabetic patients coming for elective surgical procedures.

Read the detailed description

Any surgical procedure carries an inherent risk of pulmonary aspiration. Food or liquid from the stomach might be forced back up the throat from where it could enter the lungs (aspiration) resulting in serious complications prolonging the hospital stay or in extreme circumstances death.

The risk of this is slightly higher in diabetics when compared to non-diabetics as the emptying of contents from the stomach is slightly delayed. This is why people going for surgery are asked not to eat for a specific time before their surgery. Anesthesiologists have recently developed an ultrasound test to determine if there is content in a patient's stomach and how much. This test involves an ultrasound examination of the abdomen and taking some measurements on the ultrasound screen.

This study aims to evaluate the amount of fluid remaining in the stomach of diabetic patients after a standard fasting period, and compare it with non-diabetic patients coming for elective surgical procedures. The investigators also aim to find an association between the type and duration of diabetes mellitus with residual gastric volume. Episodes of intra-operative regurgitation, vomiting or aspiration will also be documented.

Keywords
Diabetes, Diabetes Mellitus, Gastric Ultrasound, Preoperative fasting, Empty Stomach, Gastric Diabetes
Medical subject headings
Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02888951
Study groupRoleWhat they receive
Diabetic GroupA group of diabetic patients who have fasted for at least 8 hours undergoing an elective surgical procedure.
Non-Diabetic GroupA group of non-diabetic patients who have fasted for at least 8 hours undergoing an elective surgical procedure.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Volume of Gastric Contents

    A "full stomach" is defined as one containing a) solid or thick fluid content or b) > 1.5 mL/kg of clear fluid.

    There are 4 categories regarding gastric contents:

    1. Empty Stomach
    2. Grade 1 Clear Fluid (fluid only observed in supine or right lateral decubitus position)
    3. Grade 2 Clear Fluid (fluid only observed in both supine and right lateral decubitus position)
    4. Solid

    Measured: Less than two hour prior to surgery

Secondary outcomes (5)
  1. Distribution of baseline gastric volume in fasted diabetic and non-diabetic patients

    Characterize the distribution of baseline gastric volume in fasted diabetic and non-diabetic patients

    Measured: Less than two hour prior to surgery

  2. Define the upper limit of normal fasting gastric volume defined as the 95th percentile

    Define the upper limit of normal fasting gastric volume defined as the 95th percentile

    Measured: Less than two hour prior to surgery

  3. Duration and degree of glycemic control with baseline gastric fluid volume amongst diabetic patients

    To study the association between type of diabetes mellitus (I or II), duration and degree of glycemic control with baseline gastric fluid volume

    Measured: Less than two hour prior to surgery

  4. Gastric volume of diabetic patients in relation with the medication/therapy used manage their diabetes.

    To study the relationship between gastric volume in diabetic patients in relation with which medication and/or treatment they use to manage their diabetes. Examples of medication or treatment include; pharmaceutical hypoglycemics, insulin, or diet controlled.

    Measured: Less than two hour prior to surgery

  5. Episodes of intra-operative regurgitation, vomiting or aspiration

    Episodes of intra-operative regurgitation, vomiting or aspiration

    Measured: Intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2016 (estimated)
  2. Study startAug 2016
  3. Primary completionJan 2021 (estimated)
  4. Study completionJan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02888951
Sponsor's protocol ID
15-8808-AE
Status last verified
Feb 2019
First submitted
22 Aug 2016
Last updated
18 Jan 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided: It is undecided at this time whether data will be shared.

Questions about this trial

What is this clinical trial studying?

An observational study of Diabetes and Diabetes Mellitus, run by University Health Network, Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anahi Perlas, MD ((416) 603-5800 ext. 5118, anahi.perlas@uhn.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Volume of Gastric Contents (time frame: Less than two hour prior to surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in